CVS Health Corp. buy Mizuho
Summary
This prediction ended on 03.05.25 with a price of €59.37. The prediction had a final performance of 12.04%. Mizuho has a follow-up prediction for CVS Health Corp. where he still thinks CVS Health Corp. is a Buy. Dividends of €1.86 are taken into consideration when calculating the performance. Mizuho has 50% into this predictionCVS Health (symbol CVS) is a health care company that operates a retail pharmacy chain and offers health care services. The company is headquartered in Rhode Island, USA and has more than 9,900 locations. CVS Health operates three business segments: Pharmacy Services, Retail/LTC and Health Care Benefits. The Pharmacy Services segment offers pharmacy benefit management solutions and includes CVS Caremark, which serves more than 94 million plan members. The Retail/LTC segment operates CVS Pharmacy, the largest pharmacy chain in the United States, and provides long-term care pharmacy services through Omnicare. The Health Care Benefits segment offers a range of health insurance products and services through Aetna, which was acquired by CVS Health in 2018.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| CVS Health Corp. | -2.213% | -2.213% | 6.592% |
| iShares Core DAX® | 0.048% | 1.311% | 11.378% |
| iShares Nasdaq 100 | 1.601% | -0.902% | 7.287% |
| iShares Nikkei 225® | 3.057% | 12.947% | 33.767% |
| iShares S&P 500 | 0.820% | 0.703% | 4.930% |
Comments by Mizuho for this prediction
In the thread CVS Health Corp. diskutieren
In the thread Trading CVS Health Corp.